GPT and metabolic dysfunction-associated steatotic liver disease: The AST/ALT ratio [22], FIB-4 index [23], APRI [24], King’s score [25], NAFLD fibrosis score [26], and Hepamet fibrosis score [27] were calculated for diabetic and nondiabetic MAFLD patients.